REFERENCES
- Hwang YS, Shen CR, Chang SHL, et al. The validity of clinical feature profiles for cytomegaloviral anterior segment infection. Graefes Arch Clin Exp Ophthalmol. 2011;249:103–10. doi:10.1007/s00417-011-1641-9.
- Carmichael A. Cytomegalovirus and the eye. Eye. 2012;26:237–40. doi:10.1038/eye.2011.327.
- Choi JA, Kim JE, Noh S-J, Kyoung Kim E, Park CK, Paik S-Y. Enhanced cytomegalovirus infection in human trabecular meshwork cells and its implication in glaucoma pathogenesis. Sci Rep. 2017;7:43349. doi:10.1038/srep43349.
- Rasmussen L, Geissler A, Cowan C, Chase A, Winters M. The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates. J Virol. 2002;76:10841–8. doi:10.1128/JVI.76.21.10841-10848.2002.
- Puchhammer-Stöckl E, Görzer I. Human cytomegalovirus: an enormous variety of strains and their possible clinical significance in the human host. Future Virol. 2011;6:259–71. doi:10.2217/fvl.10.87.
- Koizumi N, Inatomi T, Suzuki T, et al. Clinical features and management of cytomegalovirus corneal endotheliitis: analysis of 106 cases from the Japan corneal endotheliitis study. Br J Ophthalmol. 2015;99:54–8. doi:10.1136/bjophthalmol-2013-304625.
- Chan NSW, Chee SP, Caspers L, Bodaghi B. Clinical features of CMV-associated anterior uveitis. Ocul Immunol Inflamm. 2018;26:107–15. doi:10.1080/09273948.2017.1394471.
- Touhami S, Qu L, Angii M, et al. Cytomegalovirus anterior uveitis: clinical characteristics and long-term outcomes in a French series. Am J Ophthalmol. 2018;194:134–142. doi:10.1016/j.ajo.2018.07.021.
- de Schryver I, Rozenberg F, Cassoux N, et al. Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis. Br J Ophthalmol. 2006;90:852–5. doi:10.1136/bjo.2005.086546.
- Markomichelakis NN, Canakis C, Zafirakis P, Marakis T, Mallias I, Theodossiadis G. Cytomegalovirus as a cause of anterior uveitis with sectoral iris atrophy. Ophthalmology. 2002;109:879–882. doi:10.1016/s0161-6420(02)00961-2.
- Koizumi N, Suzuki T, Uno T, et al. Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology. 2008;115(292–297.e3). doi:10.1016/j.ophtha.2007.04.053.
- Yamauchi Y, Suzuki J, Sakai J, Sakamoto S, Iwasaki T, Usui M. A case of hypertensive keratouveitis with endotheliitis associated with cytomegalovirus. Ocul Immunol Inflamm. 2007;15:399–401. doi:10.1080/09273940701486795.
- Chee SP, Jap A. Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol. 2008;146(6):883–889.e1. doi:10.1016/j.ajo.2008.09.001.
- Chee S-P, Bacsal K, Jap A, Se-Thoe S-Y, Cheng CL, Tan BH. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol. 2008;145(5):834–840.e1. doi:10.1016/j.ajo.2007.12.015.
- van Boxtel LA, van der Lelij A, van der Meer J, Los LI. Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology. 2007;114:1358–62. doi:10.1016/j.ophtha.2006.10.027.
- Bojanova M, Bodaghi B, Hannachi N, et al. Measure of herpesvirus-specific ocular antibody production in patients with uveitis. J Clin Virol. 2013;58:718–21. doi:10.1016/j.jcv.2013.10.013.
- Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–16.
- de Parisot A, Kodjikian L, Errera M-H, et al. Randomized controlled trial evaluating a standardized strategy for uveitis etiologic diagnosis (ULISSE). Am J Ophthalmol. 2017;178:176–85. doi:10.1016/j.ajo.2017.03.029.
- Kam KW, Leung KS, Kwok RPW, et al. Clinical features, diagnosis and treatment outcomes of cytomegalovirus endotheliitis in Hong Kong. Acta Ophthalmol. 2018;96:e541–e542. doi:10.1111/aos.13109.
- Accorinti M, Gilardi M, Pirraglia MP, et al. Cytomegalovirus anterior uveitis: long-term follow-up of immunocompetent patients. Graefes Arch Clin Exp Ophthalmol. 2014;252:1817–24. doi:10.1007/s00417-013-2540-z.
- Antoun J, Willermain F, Makhoul D, Motulsky E, Caspers L, Relvas LJ. Topical ganciclovir in cytomegalovirus anterior uveitis. J Ocul Pharmacol Ther. 2017;33:313–8. doi:10.1089/jop.2016.0138.
- Faith SC, Durrani AF, Jhanji V. Cytomegalovirus keratitis. Curr Opin Ophthalmol. 2018;29:373–7. doi:10.1097/ICU.0000000000000481.
- Martín Ramírez A, Cardeñoso Domingo L, González Guijarro JJ. PCR multiplex for CMV detection in patients with anterior uveitis. Ocul Immunol Inflamm. 2019;27(2):197–202.
- Relvas LJM, Antoun J, de Groot-Mijnes JDF, et al. Diagnosis of cytomegalovirus anterior uveitis in two European referral centers. Ocular Immunol Inflamm. 2018;26(1):116–121.
- Chee SP, Bacsal K, Jap A, et al. Corneal endotheliitis associated with evidence of cytomegalovirus infection. Ophthalmology. 2007;114:798–803. doi:10.1016/j.ophtha.2006.10.027.
- Shiraishi A, Hara Y, Takahashi M, et al. Demonstration of. “owl’s eye” morphology by confocal microscopy in a patient with presumed cytomegalovirus corneal endotheliitis. Am J Ophthalmol. 2007;143(4):715–717. doi:10.1016/j.ajo.2006.11.026.
- Mocarski ES. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol. 2002;10:332–9. doi:10.1016/S0966-842X(02)02393-4.
- Wilkinson GW, Tomasec P, Stanton RJ, et al. Modulation of natural killer cells by human cytomegalovirus. J Clin Virol. 2008;41(3):206–212. doi:10.1016/j.jcv.2007.10.027.
- Tarragó D, Quereda C, Tenorio A. Different cytomegalovirus glycoprotein B genotype distribution in serum and cerebrospinal fluid specimens determined by a novel multiplex nested PCR. J Clin Microbiol Immunol. 2013;202(1):37–47.
- Peek R, Verbraak F, Bruinenberg M, Van der Lelij A, Van Den Horn G, Kijlstra A. Cytomegalovirus glycoprotein B genotyping in ocular fluids and blood of AIDS patients with cytomegalovirus retinitis. Invest Ophthalmol Vis Sci. 1998;39:1183–7.
- Pignatelli S, Dal Monte P, Rossini G, et al. Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol. 2003;84(Pt 3):647–55. doi:10.1099/vir.0.18704-0.
- Arav-Boger R, Battaglia CA, Lazzarotto T, et al. Cytomegalovirus (CMV)- encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection. J Infect Dis. 2006;194:464–73. doi:10.1086/505427.
- Vogel JU, Otte J, Koch F, Gümbel H, Doerr HW, Cinatl J. Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis. Med Microbiol Immunol. 2013;202:37–47. doi:10.1007/s00430-012-0244-3.
- Sijmons S, Van Ranst M, Maes P. Genomic and functional characteristics of human cytomegalovirus revealed by next-generation sequencing. Viruses. 2014;6:1049–72. doi:10.3390/v6031049.
- Hyun SJ, Sohn HJ, Lee HJ, et al. Comprehensive Analysis of Cytomegalovirus pp65 Antigen-Specific CD8+ T Cell Responses According to Human Leukocyte Antigen Class I Allotypes and Intraindividual Dominance. Front Immunol. 2017;8:1591. doi:10.3389/fimmu.2017.01591.
- Terrazzini N, Kern F. Cell-mediated immunity to human CMV infection: a brief overview. F1000Prime Rep. 2014;6:28. doi:10.12703/P.
- Hosie L, Pachnio A, Zuo J, Pearce H, Riddell S, Moss P. Cytomegalovirus-specific T cells restricted by HLA-Cw*0702 increase markedly with age and dominate the CD8+ T-cell repertoire in older people. Front Immunol. 2017;8:1776. doi:10.3389/fimmu.2017.01776.
- Hassan J, O’Neill D, Honari B, et al. Cytomegalovirus infection in Ireland: seroprevalence, HLA Class I alleles, and implications. Medicine (Baltimore). 2016;95:e2735. doi:10.1097/MD.0000000000004864.
- Schlott F, Steubl D, Ameres S, et al. Characterization and clinical enrichment of HLA-C*07:02-restricted cytomegalovirus-specific CD8+ T cells. PLoS One. 2018;13:e0193554. doi:10.1371/journal.pone.0193554.
- Guberina H, Tomoya Michita R, Dolff S, et al. Recipient HLA-G +3142 CC genotype and concentrations of soluble HLA-G impact on occurrence of CMV infection after living-donor kidney transplantation. Int J Mol Sci. 2017;18:pii:E2338. doi:10.3390/ijms18112338.
- Lurain NS, Fox AM, Lichy HM, et al. Analysis of the human cytomegalovirus genomic region from UL146 through UL147A reveals sequence hypervariability, genotypic stability, and overlapping transcripts. Virol J. 2006;3:4. doi:10.1186/1743-422X-3-99.
- Vaheri A, Keski-Oja J, Salonen EM, Koskiniemi ML. Cerebrospinal fluid IgG bands and virus-specific IgG, IgM, and IgA antibodies in herpes simplex virus encephalitis. J Neuroim J Neuroimmunol. 1982;3(4):247–261.doi:10.1016/0165-5728(82)90029-7.
- Koskiniemi ML, Vaheri A. Diagnostic value of cerebrospinal fluid antibodies in herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry. 1982;45(3):239–242. doi:10.1136/jnnp.45.3.239.
- De Simone L, Belloni L, Aldigeri R, et al. Aqueous tap and rapid diagnosis of cytomegalovirus anterior uveitis: the Reggio Emilia experience. Graefes Arch Clin Exp Ophthalmol. 2019;257(1):181–186. doi:10.1007/s00417-018-4180-9.
- Anshu A, Tan D, Chee SP, et al. Interventions for the management of CMV-associated anterior segment inflammation. Cochrane Database Syst Rev. 2017;8:CD011908.
- Wong JXH, Agrawal R, Wong EPY, Teoh SC. Efficacy and safety of topical ganciclovir in the management of cytomegalovirus (CMV)-related anterior uveitis. J Ophthalmic Inflamm Infect. 2016;6:10. doi:10.1186/s12348-016-0078-z.
- Chee SP, Jap A. Cytomegalovirus anterior uveitis: outcome of treatment. Br J Ophthalmol. 2010;94:1648–52. doi:10.1136/bjo.2009.167767.
- Wong VW, Chan CK, Leung DY, Lai TY. Long-term results of oral valganciclovir for treatment of anterior segment inflammation secondary to cytomegalovirus infection. Clin Ophthalmol Auckl NZ. 2012;6:595–600.
- Waduthantri S, Zhou L, Chee S-P. Intra-cameral level of ganciclovir gel, 0.15% following topical application for cytomegalovirus anterior segment infection: A pilot study. PloS One. 2018;13:e0191850. doi:10.1371/journal.pone.0191850.
- Antoun J, Willermain F, Makhoul D, Motulsky E, Caspers L, Relvas LJ. Topical ganciclovir in cytomegalovirus anterior uveitis. Ocul Pharmacol Ther. 2017;33:313–318. doi:10.1089/jop.2016.0138.